Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid... Show more
Oracle shares have traded in a volatile, largely rangebound fashion. Over the 30 days ending in mid-September, the stock was essentially flat, slipping about 0.2% from roughly $150.50 to around $150. The modest net change masks significant intraday swings: the stock fell 5.4% in the regular session before its earnings report on September 10, jumped more than 4% in after-hours trading, then opened up about 7.5% on September 11 before reversing to close lower. The share price remains well below its prior record and down on a year-to-date basis, reflecting an ongoing tug-of-war between evidence of booming AI demand and concern about the heavy spending required to serve it.
Oracle Corporation is a global enterprise technology company best known for its database software, but it has repositioned itself as a major cloud infrastructure provider. Its offerings span Oracle Cloud Infrastructure (OCI), the Oracle Database, Java, and a portfolio of cloud applications including Fusion back-office software, NetSuite, and industry-specific suites such as Oracle Health. Oracle competes with hyperscale cloud providers including Amazon (AMZN) Web Services, Microsoft (MSFT) Azure, and Alphabet (GOOGL) Cloud, while also collaborating with them through multicloud database partnerships. Its large AI infrastructure relationship with OpenAI and a rapidly expanding data-center buildout have made the stock a closely watched proxy for the AI infrastructure trade.
The dominant catalyst has been Oracle's fiscal first-quarter 2027 results, reported September 10. Revenue climbed 30% year over year to $19.3 billion, and adjusted earnings per share rose 30% to $1.92, exceeding consensus estimates of about $1.74. Cloud infrastructure (IaaS) revenue was the standout, up 121% to $7.4 billion, while total cloud revenue grew 62% to $11.6 billion and cloud applications rose 10%.
Oracle signed more than $30 billion in new AI cloud contracts during the quarter, lifting RPO to a record $664 billion, up about $209 billion year over year. Management said roughly half of that backlog could convert to revenue within 36 months. The company also delivered 850 megawatts of new data-center capacity and more than 300,000 GPUs, with AI infrastructure utilization running at 97.9%.
The flip side is capital intensity. Quarterly capital expenditures reached about $28 billion, versus roughly $8.5 billion a year earlier, and free cash flow was negative. Oracle completed a previously disclosed $20 billion at-the-market equity offering during the quarter and reaffirmed full-year capital-spending guidance of $90 billion to $95 billion. Analyst reactions were broadly positive but mixed on valuation: Guggenheim reiterated a Buy with a $400 price target, Citizens JMP maintained a Market Outperform rating with a $285 target, and DA Davidson kept a Buy at $225, while Stephens remained at Equal Weight with a $175 target. The stock's same-day reversal underscored that even strong results are being weighed against cash-flow concerns.
For investors seeking a more systematic approach, Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are surfaced in this section. These bots differ in strategy, timeframe, and performance metrics, giving traders a range of approaches to explore. The page provides a practical way to review automated trading tools that operate around the clock, complementing traditional research. Investors interested in data-driven strategies can browse the available bots to see which align with their own objectives.
Several factors are likely to shape Oracle's path through the remainder of 2026 and into fiscal 2027. Investors will watch whether the record RPO backlog converts into revenue at the pace management projects, and whether capital spending of $90 billion to $95 billion can be funded without excessive dilution or further pressure on free cash flow. The company's guidance for fiscal second-quarter revenue growth of 30% to 34% and cloud revenue growth of 65% to 71% offers a near-term benchmark.
Beyond earnings, scheduled events such as the Oracle AI World event and an investor day in late October are expected to provide more detail on product strategy and long-term financial targets. The health of the broader AI trade, demand from major customers including OpenAI, competitive dynamics with hyperscalers and chip suppliers such as Nvidia (NVDA), and macroeconomic conditions will also influence sentiment. Given the stock's sensitivity to both AI demand signals and cash-flow metrics, upcoming quarters are likely to hinge on the balance between backlog growth and capital discipline.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
On September 21, 2026, the Stochastic Oscillator for ORCL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In 43 of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over 75%.
ORCL moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +7.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in 229 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 184 of 289 cases where ORCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In 46 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for ORCL turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 24 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
ORCL broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 24 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.220) is normal, around the industry mean (19.972). P/E Ratio (23.136) is within average values for comparable stocks, (153.820). Projected Growth (PEG Ratio) (0.827) is also within normal values, averaging (3.697). Dividend Yield (0.014) settles around the average of (0.004) among similar stocks. P/S Ratio (5.858) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of a diversified line of business software products
Industry ComputerCommunications